Page 2 - Binding Domain News Today

Salimetrics Launches Saliva Testing with Industry-Leading SARS-CoV-2 IgG Antibody Multiplex Assay Used in Vaccine Clinical Trials Share Article Salimetrics now offers multiplex testing for antibodies against SARS-CoV-2 Nucleocapsid, Spike 1, and Spike 1 Receptor Binding Domain (RBD) using a single, easy-to-collect saliva sample. Researchers now have unparalleled access to saliva collection devices and COVID-19 antibody saliva testing on a robust and validated platform. This effort provides an u...

Pharma wrap: Significance of ICMRs latest COVID-19 seroprevalence study The latest survey illustrates that the COVID-19 is much widespread than the cases that were detected. India has reported 10.8 million cases so far. February 07, 2021 / 02:17 PM IST Mumbai’s local trains resume: Commuters wearing protective face masks travel in a suburban train after authorities resumed Mumbai’s train services for all commuters after it was shut down to prevent the spread of COVID-19, on February 1, ...

The sero-prevalence in the population above the age of 18 years was 21.4 per cent in the third sero-survey conducted from December 17, 2020 to January 8, 2021, said the Indian Council of Medical Research (ICMR) on Thursday. During a press conference, Balram Bhargava, DG ICMR said that a total of 7,171 healthcare workers were included among the 28,589 individuals in the third sero-survey. "The third sero-survey was done from December 17, 2020, to January 8, 2021. A general population of 28,58...

21.4 pc sero-prevalence among population of over 18 years: ICMR ANI | Updated: Feb 04, 2021 16:56 IST New Delhi [India], February 4 (ANI): The sero-prevalence in the population above the age of 18 years was 21.4 per cent in the third sero-survey conducted from December 17, 2020 to January 8, 2021, said the Indian Council of Medical Research (ICMR) on Thursday. During a press conference, Balram Bhargava, DG ICMR said that a total of 7,171 healthcare workers ...